OverviewSuggest Edit

Stereotaxis specializes in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. The Company's' core technologies are the Niobe ES Remote Magnetic Navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems and the Vdrive Robotic Mechanical Navigation system and consumables.
TypePublic
Founded1990
HQSt. Louis, US
Websitestereotaxis.com
Employee Ratings3

Latest Updates

Employees (est.) (Dec 2019)118
Job Openings5
Revenue (FY, 2019)$28.9 M(-1%)
Share Price (Oct 2020)$3.3 (-1%)
Cybersecurity ratingCMore

Key People/Management at Stereotaxis

Nathan Fischel

Nathan Fischel

Director
David W. Benfer

David W. Benfer

Lead Independent Director
Arun Menawat

Arun Menawat

Director
Robert J. Messey

Robert J. Messey

Director
Joe Kiani

Joe Kiani

Director
Ross B. Levin

Ross B. Levin

Director
Show more

Stereotaxis Office Locations

Stereotaxis has offices in St. Louis, Xicheng Qu, Shinjuku and Wormerveer
St. Louis, US (HQ)
Cortex 1, 4320 Forest Park Ave #100
Xicheng Qu, CN
511 1 Nao Shi Kou Da Jie
Wormerveer, NL
67 Zaanweg
Show all (4)

Stereotaxis Financials and Metrics

Stereotaxis Revenue

Embed Graph
View revenue for all periods
Stereotaxis's revenue was reported to be $28.90 m in FY, 2019
USD

Revenue (Q2, 2020)

5.3m

Gross profit (Q2, 2020)

4.3m

Gross profit margin (Q2, 2020), %

79.7%

Net income (Q2, 2020)

(1.9m)

EBIT (Q2, 2020)

(1.9m)

Market capitalization (29-Oct-2020)

238.1m

Closing stock price (29-Oct-2020)

3.3

Cash (30-Jun-2020)

44.0m

EV

197.3m
Stereotaxis's current market capitalization is $238.1 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

42.0m46.6m38.0m35.0m37.7m32.2m31.1m29.3m28.9m

Revenue growth, %

(8%)8%(15%)

Cost of goods sold

12.5m14.8m11.0m8.2m10.4m7.5m10.8m5.7m6.1m

Gross profit

29.5m31.8m27.0m26.8m27.2m24.6m20.4m23.6m22.8m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

11.6m8.5m12.3m10.5m8.4m9.7m10.8m8.4m8.0m8.9m9.5m9.7m9.3m8.6m7.9m8.3m7.0m8.5m8.1m7.0m7.6m7.6m7.0m6.8m8.2m5.8m5.3m

Cost of goods sold

3.5m2.7m3.8m3.3m2.2m2.5m3.5m1.6m2.0m2.3m2.6m2.9m2.4m2.2m1.1m2.3m1.3m2.2m1.9m1.3m1.4m1.6m1.4m1.1m1.8m951.4k1.1m

Gross profit

8.1m5.9m8.5m7.3m6.2m7.3m7.3m6.7m6.1m6.5m6.9m6.7m6.8m6.5m6.8m6.1m5.7m6.3m6.2m5.7m6.2m5.9m5.6m5.7m6.4m4.8m4.3m

Gross profit Margin, %

70%69%69%69%74%75%68%81%75%74%72%70%74%75%86%73%82%74%76%82%82%78%80%83%78%83%80%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

14.0m7.8m13.8m7.3m5.6m8.5m3.7m10.8m30.2m

Accounts Receivable

11.1m11.6m7.6m6.5m6.4m1.1m4.3m5.0m5.3m

Prepaid Expenses

3.1m3.5m1.9m1.1m785.2k750.1k963.7k1.5m

Inventories

6.0m5.1m4.9m6.4m4.5m5.4m1.1m1.2m1.8m
USDQ2, 2011

Financial Leverage

-7 x
Show all financial metrics

Stereotaxis Cybersecurity Score

Cybersecurity ratingPremium dataset

C

78/100

SecurityScorecard logo

Stereotaxis Online and Social Media Presence

Embed Graph

Stereotaxis News and Updates

Stereotaxis to Present at Three Investor Conferences in September

ST. LOUIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and CEO, will present at three investor conferences in September 2020.

Robotic Catheter System Market Next Big Thing | Major Giants Catheter Precision, Hansen Medical, Stereotaxis

Stay up-to-date with Robotic Catheter System Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday

Stereotaxis Reports 2020 Second Quarter Financial Results

ST. LOUIS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the second quarter ended June 30, 2020.

Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference

ST. LOUIS, June 18, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and CEO, will present at the Cowen 5th Annual FutureHealth Conference on Thursday, June…

Stereotaxis Reports 2019 Full Year Financial Results

ST. LOUIS, March 10, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended December 31, 2019.

Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System

ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the Genesis RMN® System for the robotic…
Show more

Stereotaxis Blogs

Dr. Subhashini Gowda

Dr. Subhashini Gowda of Robert Wood Johnson University Hospital in New Jersey has relied on Niobe technology for eight years in managing a vibrant practice. “The Niobe system has allowed me to successfully manage a busy complex ablation program, while providing the best possible patient care,” she s…

Dr. Jay Tiongson

Work with hands. Check. Use novel technologies. Check. Save lives and improve quality of life. Check, check. When considering how he wanted to spend his professional life, EP checked all the boxes for Dr. Jay Tiongson of Mission Hospital in California. “The ability to affect people’s lives so profou…

Dr. Erik Sirulnick

For Dr. Erik Sirulnick, his first case on the Niobe system “seems long ago.” Actually, the EP lab at Desert Springs Hospital in Las Vegas acquired the Niobe in 2015, becoming the first in Nevada to use robotic navigation for cardiac ablation. “We have had so many successful experiences with it,” he …

Dr. Dhanunjaya “DJ” Lakkireddy

Dr. Dhanunjaya “DJ” Lakkireddy is an EP’s EP in every sense. He literally has his fingers on the pulse of care and innovation for the body, mind and spirit of patients with complicated arrhythmias. At his Kansas City practice, DJ explores disease management from every angle, which includes identifyi…

Dr. Darren Peress

“One of my guiding principles has been to treat every patient as I would my own family member,” says Dr. Darren Peress from Tucson Medical Center in Arizona. “With Stereotaxis technology, I have the confidence that I’m providing the safest, most advanced therapy for complex arrhythmias.” Performing …

Dr. Bill Spear

Dr. Bill Spear is fascinated by the physiology of cardiology. His interest in the chemical and electrical process that creates a functioning heart beat drew him into the field of EP. As one of the early adopters of Stereotaxis Robotic Navigation, Dr. Spear helped pioneer “Best Practices” which furth…
Show more

Stereotaxis Frequently Asked Questions

  • When was Stereotaxis founded?

    Stereotaxis was founded in 1990.

  • Who are Stereotaxis key executives?

    Stereotaxis's key executives are Nathan Fischel, David W. Benfer and Arun Menawat.

  • How many employees does Stereotaxis have?

    Stereotaxis has 118 employees.

  • What is Stereotaxis revenue?

    Latest Stereotaxis annual revenue is $28.9 m.

  • What is Stereotaxis revenue per employee?

    Latest Stereotaxis revenue per employee is $244.9 k.

  • Who are Stereotaxis competitors?

    Competitors of Stereotaxis include PRECEYES, ValueBioTech and Microsure.

  • Where is Stereotaxis headquarters?

    Stereotaxis headquarters is located at Cortex 1, 4320 Forest Park Ave #100, St. Louis.

  • Where are Stereotaxis offices?

    Stereotaxis has offices in St. Louis, Xicheng Qu, Shinjuku and Wormerveer.

  • How many offices does Stereotaxis have?

    Stereotaxis has 4 offices.